KRISTIN RYAN: Open Payments
NPI 1972042521 · ARLINGTON HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,357 in 79 payments from 15 companies in 2025. Trend: 2023 $1,358 · 2024 $726 · 2025 $1,357
Food & beverage: $1,357
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $192 |
| Amgen Inc. | 13 | $190 |
| Corcept Therapeutics | 8 | $178 |
| ABBVIE INC. | 12 | $173 |
| Lilly USA, LLC | 9 | $142 |
| Abbott Laboratories | 4 | $87 |
| Tandem Diabetes Care, Inc. | 4 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75 |
| Radius Health, Inc. | 3 | $59 |
| Xeris Pharmaceuticals, Inc. | 3 | $46 |
Products named: Korlym, MOUNJARO, TEPEZZA, UBRELVY, FREESTYLE LIBRE 3, t:slim X2 Insulin Pump with Control-IQ, Wegovy, JARDIANCE.
Industry payments across IL — which companies pay providers there.
